DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 40 filers reported holding DIAMEDICA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $89,311 | -42.4% | 34,617 | -3.6% | 0.00% | – |
| Q2 2023 | $155,062 | +181.0% | 35,894 | -0.5% | 0.00% | – |
| Q1 2023 | $55,175 | -3.2% | 36,062 | 0.0% | 0.00% | – |
| Q4 2022 | $56,982 | +26.6% | 36,062 | -0.5% | 0.00% | – |
| Q3 2022 | $45,000 | -38.4% | 36,248 | 0.0% | 0.00% | – |
| Q2 2022 | $73,000 | -19.8% | 36,248 | -0.5% | 0.00% | – |
| Q1 2022 | $91,000 | -51.1% | 36,412 | -27.0% | 0.00% | – |
| Q4 2021 | $186,000 | -7.0% | 49,884 | 0.0% | 0.00% | – |
| Q3 2021 | $200,000 | +17.6% | 49,884 | +30.3% | 0.00% | – |
| Q2 2021 | $170,000 | -54.2% | 38,284 | -5.6% | 0.00% | – |
| Q1 2021 | $371,000 | -14.7% | 40,576 | -5.4% | 0.00% | – |
| Q4 2020 | $435,000 | +663.2% | 42,905 | +218.5% | 0.00% | – |
| Q3 2020 | $57,000 | -38.7% | 13,472 | 0.0% | 0.00% | – |
| Q2 2020 | $93,000 | – | 13,472 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,146,470 | $4,861,000 | 5.06% |
| Corriente Advisors, LLC | 730,000 | $3,095,000 | 1.57% |
| Manatuck Hill Partners, LLC | 571,500 | $2,423,000 | 1.11% |
| CVI Holdings, LLC | 276,176 | $1,171,000 | 0.48% |
| DAFNA Capital Management LLC | 156,529 | $664,000 | 0.22% |
| Worth Venture Partners, LLC | 42,887 | $182,000 | 0.15% |
| Granite Point Capital Management, L.P. | 646,855 | $2,743,000 | 0.15% |
| Ikarian Capital, LLC | 415,000 | $1,759,000 | 0.13% |
| Maven Securities LTD | 359,285 | $1,473,000 | 0.12% |
| Nantahala Capital Management | 756,193 | $3,206,000 | 0.10% |